Joinn Laboratories (China) Co.,Ltd. provided unaudited earnings guidance for the year ended December 31, 2021. For the year, the company is expecting to record (i) a net profit attributable to equity shareholders of the Company of approximately RMB 542.79 million to RMB 574.29 million for the year ended 31 December 2021, being an increase of approximately 72.3% to 82.3% as compared with RMB 315.01 million as recorded in the corresponding period in 2020; and (ii) a net profit attributable to equity shareholders of the Company adjusted for non-recurring profit after deduction of income tax of approximately RMB 515.54 million to RMB 547.04 million for the year ended 31 December 2021, being an increase of approximately 76.6% to 87.4% as compared with RMB 291.92 million as recorded in the corresponding
period in 2020.